If you are eating less foodand therefore fewer mineral-dense vegetablesyour levels can tank quickly
The use of this term is conducive to its prevention and control for early intervention with every risk factor of MDSRCKD instead of the conventional glycemic-control-centered management
Ghusn W, Hurtado MD (2024) Glucagon-like Receptor-1 agonists for obesity: Weight loss outcomes, tolerability, side effects, and risks
10.1016/S0140-6736(12)61267-7 22 BuseJ
Combination with SGLT2 inhibitors to augment the benefits of this drug class in HFrEF with, for example, the weight-lowering effects of GLP-1 RA could offer a clinically valuable and feasible option addressing the spectrum of abnormalities associated with this HF phenotype
Magnesium repletion may modestly increase insulin sensitivity in deficient patients, potentially adding to the sulfonylurea's glucose-lowering effect